Clinical Trial Update: Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy

View source ↗

Summary

A clinical trial update on Pfizer's ABRYSVO maternal RSV vaccine during pregnancy, focusing on its impact and effectiveness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• ABRYSVO

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Virus, Respiratory Tract Diseases | Status: ACTIVE_NOT_RECRUITING